ACORDA THERAPEUTICS INC·4

Aug 3, 4:08 PM ET

RAUSCHER STEVEN M 4

4 · ACORDA THERAPEUTICS INC · Filed Aug 3, 2017

Insider Transaction Report

Form 4
Period: 2017-08-01
Transactions
  • Exercise/Conversion

    Common Stock

    2017-08-01$18.21/sh+10,000$182,10010,000 total
  • Exercise/Conversion

    Non-Employee Stock Option

    2017-08-0110,0000 total
    Exercise: $18.21Exp: 2017-08-06Common Stock (10,000 underlying)
  • Sale

    Common Stock

    2017-08-01$21.57/sh10,000$215,7030 total
Footnotes (3)
  • [F1]Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2017 on the expiration date reported within Table II unless exercised.
  • [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $21.30 to $21.95 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The shares subject to these options vested in installments and were fully vested on 06/05/2008.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION